Clinical trials
Completed Hemoglobinopathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 5 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| University of California, San Francisco | 4 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Bangladesh Bioscience Research Group | 2 |
| Hillhurst Biopharmaceuticals, Inc. | 2 |
| University of British Columbia | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Augusta University | 1 |
| Bacha Khan Medical College | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemoglobinopathies | 41 |
| Anemia, Sickle Cell | 24 |
| Thalassemia | 18 |
| Hematologic Diseases | 12 |
| Anemia | 7 |
| Immunologic Deficiency Syndromes | 7 |
| beta-Thalassemia | 7 |
| Fanconi Anemia | 4 |
| Genetic Diseases, Inborn | 4 |
| Hematologic Neoplasms | 4 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.